Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director comp.
LadRx Corp (CYTR) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2011 BW CytRx Receives FDA Orphan Drug Designation for INNO-206 for the Treatment of Soft Tissue Sarcomas
05/16/2011 BW CytRx Completes Sale of Molecular Chaperone Assets to Orphazyme ApS in Deal Worth up to $120 Million
04/18/2011 BW CytRx Announces the Publication of a Peer-Reviewed Case Report Documenting Tamibarotene's Successful Elimination of Recurrent Advanced-Stage Leukemia
04/11/2011 BW CytRx Receives Shares of ADVENTRX Pharmaceuticals in SynthRx Transaction
03/28/2011 BW CytRx Announces the Presentation of Bafetinib Study Results at the American Academy for Cancer Research (AACR) Annual Meeting
03/11/2011 BW CytRx Reports 2010 Financial Results
03/07/2011 BW CytRx to Present at the ROTH Capital Partners 23rd Annual OC Growth Stock Conference
11/10/2010 BW CytRx Initiates Pharmacokinetic Clinical Trial with Bafetinib in Brain Cancer
11/08/2010 BW CytRx Reports Third Quarter Financial Results
11/02/2010 BW CytRx Awarded $735,000 Grant under the Qualifying Therapeutic Discovery Project Program
09/08/2010 BW CytRx to Present at Rodman & Renshaw 12th Annual Healthcare Conference
08/09/2010 BW CytRx Reports 2010 Second Quarter Financial Results
07/22/2010 BW CytRx's Tamibarotene Eradicates Cancer in Advanced Acute Promyelocytic Leukemia After Failure of Other Therapies
07/19/2010 BW CytRx Announces Substantial Progress with Its Bafetinib Clinical Trials Program
06/14/2010 BW CytRx Set to Join the Russell 3000 Index
05/11/2010 BW CytRx to Present at the Rodman & Renshaw Annual Global Healthcare Conference in London
05/06/2010 BW CytRx Reports 2010 First Quarter Financial Results
05/03/2010 BW CytRx's INNO-206 Rapidly Shrinks Human Tumors in an Animal Model of Multiple Myeloma
04/20/2010 BW CytRx's Bafetinib Receives Positive Opinion from the Committee for Orphan Medicinal Products in the European Union for Treatment of CML
03/23/2010 BW CytRx to Receive $3.8 Million from Sale of RXi Pharmaceuticals Common Stock
03/15/2010 BW CytRx Reports 2009 Fourth Quarter Financial Results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy